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BIWIC 2009/16'"InternationalWorkshop 00 Industrial Crystallization.
September9-11, 2009, Departmentof Chemical Technology,
LappeenrantaUniversity ofTechnology. Preface
Eds.: Marjatta Louhi-Kultanen, Henry Hatakka
Departmentof Chemical Tcchnology
LappccnrantaUniversity ofTechnology
1'.0. Box 20 (Skinnarilankatu 34)
FIN-53851 Lappeenranta
It is our great pleasure to host BIWIC 2009, the 16th International Wurkshop on Industrial
Crystalhzation, atLappeenrantaUniversity ofTechnology. The eventcontinuesthe successful
seriesof meetings initiated primarily by Joachim Ulrich and follows on from gatheringsheld
in Bremen,Delft,Rouen,Gyeongju,Halle,Cape Town, andlastyearin Magdeburg.This
yearBIWIC 2009brings togetherover 60 participantsfrom Europe, China, Iran, Japan, Korea
and Thailand.
Finland Organizationof BIWIC 2009hasheenin the capablehandsof the scientificand local




Crystalhzation, the themeof theworkshop, is widely used as a purification, concentrationand
separationmethodwhen a pure crystalline substancewith specific particle propertiesneedsto
be isolated from a muhi-component processsolution. Crystallization of organic compounds is
generally followed by a synthesis, extraction or bio-process. The main challenges facing
industrial crystalhzation are how to control crystal morphology, crystal size distributioo and
1'01ymorphism.
BIWIC 2009coversa widerangeof interestingandexcitingtopics.A significantnumberof
BIWIC 2009contributionsareon crystallizationof pharmaceuticalcompounds.An example
is the isolatiunand purificationof a drugmoleculeby crystallizationfrom a traditional
Chineseplant.Novelcrystallizationapplicationscanbefoundin biotechnologyprocesses,the
significanceof whichcanbeexpectedtoincreasein thenearfuture.It seemsthattherewill be
a needto developnewmethodsto identifyandseparatepotentialfine chemicalsin bio-
refineriesfor tbepbarmaceutical,foodandchemicaliodustry,or toisolateharmfulsubstances
from fermentationbroths.A furthernew applicationexampleis the purificationof ionic
liquids by crystallization.In the food industry, ice crystallizationand other melt
crystallizationmethodsare usedas concentrationor purificationmethods.Spectroscopic
analysismethodsallowin-linereal-timeprocessmonitoringandprocesscontrol.Precipitation
of nano-sizedcrystalsis a furthertopic of BIWIC 2009 presentations.In additionto
crystallization,effectivedown-streamprocessing(filtrationof crystalsfrom motherliquor,




We hopethismeetingof expertsin thefieldwill helpcrystallizenewideasandapproaches.
Wewishyouafru'itfulandmemorablexperienceatBIWIC 2009.
LappcenrantaUniversity ofTechnology, Finland
Digipaino Marjatta Louhi-Kultanen and Henry Hatakka
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The disadvantagewas a polymorphic mixture due 10the violent releaseof the supersaturalion.




OrganicCompoundB wascrystallizedin liquid-liquidsyslcmby evaporalionin order10
producecry,tals of micronizedgrade,and ,imultaneouslyfor Ihe removalof the main
impurityB-Y-B. Likewise,supersaturationwas achievedby evaporationof morevolatile
componentfromthedropandalsoby coolingthedispe"ion.As a r",ult, crystalsizewas50
% ~13~m,andthemainimpurityB-Y-B reducedto UI4 partof thecrudematerialimpurity
level.Accordingto lab-scalefiltrationnomajorproblemswereexpectedin scale-uppossibly
dueto highcrystallinityof theproduct.Theyieldmetexpectationsbecauseof highimpurily
removalevelin thecrudeCompoundB.
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In this work, thefeasibilityof usinga chromatogrophy-crystallizationhyhridseparation
processfor the isolationand purificationof artemisininfrom the Iterhalplant Artemisia
annuawasstudied.A two"stepanti-solventcrystallizationprocesswasproposedbasedontlte
solubilityof artemisininin differentsolvents.Thefirst stepcrystallizationprocesswasto
removethe impuritiesfrom tltesolutionand the secondstepto isolateartemisinin.The
Cly.,.tallizationbehaviourof the two polymorphsof artemisininduring the anti-sol",,,
Clystallizutionprocess was also studiedby performingcrystallizationin solutiansof
urtemisininin acetonitrileandacetone,respectively.It wasobservedthattlteformationof the
twopalymorphsofartemi.,ininin acetonesolutionfollowstheOstwald'smleofstages.A fast
feedingof theanti~solvent(water),'c.,ultedin thecrystallizationaf themetastabletriclinic
formwltilethe"'ableorthorhamhicformClystallizedoutwhenwuterwasfed slowly.Finally,
a chromatogmphy-crystallizationhybridseparationprocesswasproposedandtested.The
resultsof thepresentworkdemonstrateda greatpotentialof combiningtheadvantagesof
columnchromatographyand crystallizationto improvethe efficiencyof the isolationof
actemisininfromtheplantArtemisiaannua.
4 Conclusion
The formationpolymorphicmixturewasa problemin caseof CompoundA crystallization,
andsphericalagglomeration(SA) or trueemulsionsolventdiffusion(ESD)methodwouldbe
moresuitable.However, thepresentedmethodcouldbeapplicableforothercompounds.
The presentedmethodcan be appliedin industrialscalefor the caseof CompoundB
crystallization.However,optimizationfor theremovalof impurityB-Y-C shouldbedone,






Artcmisininis a sesquiterpenelactoneperoxidederivedfrom theChinesemedicinalherh
Anemisiaannua.It is the mosteffectivedrugagainstchloroquine-resistantPlasmodium
falciparuminfectionand eerehralmalaria[1-3]. In addition,the anticanceractivity of
artemisininand its activityagainstotherparasitespecieshave also beenreported[4].
Consequently,the worldwidedemandof artemisininis continuouslyincreasing.The total
synthesisof artemisinin hasbeendiscoveredin the1980s[5],however,thecomplexstepsand
theeelativelylow yield of the syntheticapproachhas limitedits applicationto the real
industrialproductionof artemisinin.Currently,the extractionfrom A. annuo is the only
Sou"eeof artemisininin the market.In orderto developa reliablemarketsupply of
artemisininwithareasonableprice,it isparamountimportancetodotheresearchtowardsthe
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A Iypical isolalion and purification process for artcmisinin from A. annua consists of Ihe
extraction of the plant material and the separation of artemisinin from other compounds
extractedfrom the plant. The separationof artemisinin from the extracts is very challenging
due to the extremecomplexity of the extractsand the presenceof compounds in the extracts
of which many have chemical structuresvery similar to artemisinin (as shown in Fig. I) and
hence similar chemical and chromatographic characteristics [6]. Purification of the crude
extract by chromatographic methods followed by crystallization of the pure artemisinin is
usually involved in separatedsteps.In principle, complete separationof the compounds from
the crude extractscanbe achieved by column chromatography(Cc:) using a sufficiently long
column. However, thecapital and operational costs of theseparationprocesscanbe very high
in such cases,and thus increasethe tolal manufacturingcost of theproduct. In practice many
of the extractionplants located in the traditionalcultivation and processingarcas of A. annua,
e.g., China and Vietnam have excluded the chromatographicpurification stepand solely use
crystallization for separation.In order to producea high-purity product, artemisininhas to be
rc-crystallized several times, which leads to significant loss of the product. It has been
reported from two extraction plants in Vietnam that the yield of artemisinin was
approximately 0.2-D.3 % based on dry plant. However, the analysis of theseA. annua plants
showed thatthe concentrationof artemisinin in the dry plant was 0.8-1 % [7]. Obviously, the
profitability of this processmight becomeunacceptablein a country where the cost for plant
cultivation is much higher Ihan in Vietnam and the environmentalregulationsare more striet.
The development of an artemisinin production process in such eountries requires a well-
designedand more efficient isolation and purification procedure.
of otherimpuritycompounds,especiallythosepossessingsimilarmolecularstrucluresasIhe
crystallizingproduct.Therefore,thehybridbetweenchromatographyanderyslallizationcan
havea synergisticeffect,which can be developedas a robustand efficientseparation
approachfor theisolalionof bioactivecompoundsfroma complexmulti-componentsmixlure
(8].
In additionto separationandpurification,crystallizationis alsoa techniquefor solid form
selection.Sincethedifferentsolidfonnsmayhavedistinctphysicalandchemicalproperties,
suchassolubilily,dissolutionrate,density,thermalandchemicalstabilily,thecontrolof Ihe
polymorphismof thecrystallineproductduringtheprocessingis oneof themostimportanl
issuesin pham1aceuticalindus!ry.It hasbeenreportedthatartemisininis eapableof forming
twopolymorphs,anorthorhombicformanda triclinicfonn [9].However,thecrystallization
behaviouroflhe twopolymorphsofartemisininhasn'tbeensludied.
Theobjectiveof thepresentworkis toexplorethefeasibilityof combiningIheadvantagesof
bolh chromatographyand crystallizationto generalea hybridseparalionprocessfor the




and crystallizationbehaviourof artemisinin,a chromatography--<rystallizalionhybrid









ThepureartemisininwasobtainedfromMy Dinh Extractionplantin VietnamandXiangXi
HolleyPhannaceuticalCo. Ltd. in China.Thepurityof thematerialis >99%.The organic
solventsused in all experimentsare HPLC grade from Fisher Scientific(Slangerup,




3 Mem's'';;'r acid 4 Mem'sitene 2.2Solubilitymeasuremenl
The solubilityof pure artemisininin variousorganicsolventsand solventmixtureswas
measuredat room temperature.The organicsolventsused includeethanol,methanol,
dichloromethane,acetonitrile,acetone,ethyl acetate,hexane,and chiorofonn.The mixed
solventsarebinarymixturesof acelonitrile-waterandethanol-water.Ten mL soiventwilh
excessartemisininwasaddedto a 25 mL flask.The liquid-solidsuspensionwasthenkept
undermixingin a waterbathat24.5cC for2 h.Theclearsolutionwasthenremovedwitha
syringefilter.Onemt clearsolutionwassampledandafterdilution,it wasanalyzedwithan
Agilent1100seriesHigh-PerfonnanceLiquidChromatography(HPLC) equippedwithaPDA
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2.3Anti-solventcrystallizationof artemisinln
Theanti-solvenlcrystallizationof artemisininwasperformedbyfeedingwalertoIhesolulion
of artemisininin acetoneand aCelOnilrile,respeclively.One mL artemisinin-acetoneor
artemisinin-acetonitrilesolutionsaturatedal roomtemperaturewas preparedin an 8 mL
flask.A magneticmixerwasusedto providethemixingof Ihesolution.Waterwasfedto the
solutionwilh twodifferentfeedingmodes:in theslow feedingmode,waterwasfedwitha
20-~Lpipetteata flow rateof 20 ~LImin.Thesolutionbecameturbidafter30-40~L water
wasadded.After that,thefeedingflow rateof waterwasincreasedgradually,andfinally6
mL waterwasfedto thesolutionwithin I h. Forthefaslfeedingmode,the6 mL waterwas
addedrapidlywitha pipette.The suspensionwasthenfilteredandthecrystalsweredriedat
room lemperatureovernight.The X-ray powderditTractionpatternsof Ihe crystalswere
collectedwith a PANalyticalX'Pert PRO X-Ray DitTractometer(Almelo, Netherlands)to
identifythepolymo']Jhismoflhe producedcrystals.
beinsolubleinwaterandoilbutsolubleinmostaproticorgaoicsolvents.It caobeseenfrom
Fig.2 thatartemisinins moresolublein thesolventswithmediumpolarity(solubility
purameterbetween18-24).Inaddition,thechemicalslruetureofthesolventalsosignificantly
atTectsthesolnbilizationpotentialof thesolvent.Ethylacetateandacetonehavesimilar
solubilityparameteras chloroformand dichloromclhane,however,the solubilityof
artemisininchloroformanddichloromethaneis about5 timcshigherthanthatin ethylcetateandacetone.













Aarslev,Universityof Aarhusin 2006and2007,andwasstoredat-20 °C untilextraction.
The plantmaterialwascut ioto smallpiecesandextractedwith dichloromethaneat room







3015 20 252.5 Chromatography-crystallizationhybridseparationprocess
The combined extractswere separatedusing flash CC on silica gel (silica gel 60, particle size
~0.063mm)andelutedwithdichloromethane.Theratioof solutetoabsorbentwas 1:30. The
fractionsweremoniloredby thin layerchromatography(TLC). TLC plateswerenormal-
phasesilicagel60 F254nm20x20cm fromMerck(KGaA, Germany)andthemobilephase
was diehlornmethane.Plateswere inspectedby UV lighl followedby visualizationwith




Fig. 2 Solubilityof artemisininin ditTerentorganicsolventsat roomtemperature(24'soC)(measuredwithgravimetricmethod).
The solubilityof artemisinini aqueousacetonitrileandethanolsolutionswerealso
measured.TheresultsarcshowninFig.3.Thesolubilityofartemisininremarkablydecreased
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Thesolnbilityofartemisinindifferentorganicsolventsi showninTableI andin Fig.2
againsttheHildebrandsolubililyparameterof thesolvent.Artemisininhasbeenreportedto
lit
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Fig. 3 Solubility of artemisinin in mixed solvents.
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3.2Crystallizationbehaviourof artemisinln
Artemisininis capableof fanning two differentpolymorphs,theorthorhombicfonn with
higherdensityandlowersolubilityin wateris consideredas thethennodynamicallystable
format roomtemperature,andthe triclinicfonn is themetastableone.The X-ray Powder
Diffraction(XRPD) patternsof the artemisinincrystalsresultedfrom the anti-solvent
crystallizationfromacetoneandacetonitrilesolutionsis shownin Fig.4. It wasobservedthat
thefonnationof thepolymorphsof artemisinindependentonthesolventandthegeneratiou
rate of supersaturation.The crystallizationof the two polymorphsof artemisininfrom
acetonitrilesolution does not follow the well known Ostwald's mle of stages,the
orthorhombicformalwayscrystallizedoutregardlessof thefeedingrateof theanti-solvent.
On the contrary,thepolymorphicstateof artemisinincrystallizedfrom acetonesolution
dependedonthefeedingrateoftheanti-solvent.Whentheanti-solventwasaddedrapidly,the
crystallizationof thepolymorphsfollowedtheOstwald'sruleof stages,andthemetastable
trielinic fonn crystallizedout firstly. Whenthe crystallizationwas performedwith slow
feedingof anti-solvent,thefinal crystalproductwas identifiedas thestableorthorhombic
form.In orderto studytheeffectsof thesolventson thepolymorphsfonnation,thecrystals
resultedfromthesolventevaporationin solubilitymeasurementwerealsoanalyzedwithX-
ray diffractometer.The crystalsdriedfrom ethylacetatesolutionwerepuretrieliniefonn,
while thecrystalsfrom theothersolventswereall orthorhombicform.This observation
suggestedthatethylacetatecanpromotethefonnationof themetastabletrielinieform.
3.3Crystalllzatlouofartemislnlnfromcolumnchromatographyfractions
ThefractionsobtainedbyCC of anextractofA. annuaandcontainingartemisininwere
elassifiedintofourgroupsandwerefurthercombinedintofourmixtureswiththefollowing
volumeandartemisininconcentrations:
(The concentrationof artemisininin thecombinedfractionswasquantifiedwitha Thenno
ScientificLTQXL AP-ESI LC-MS [10];The compositionof the combinedfractionswas
assessedbyTLC, andtheelutionsequenceof thecompoundsare:A-B-Artemisinin-c.)
All of the solutionscontainartemisininand one or two othercompounds,which are
consideredastheimpurityin thecrystallizationstep.Basedonthesolubilityof artemisininin
dichloromethaneand acetonitrile,when acetonitrileis fed to a saturatedartemisinin-
dichloromethanesolution,noartemisinincanbecrystallizedout.In thefollowing(Fig.5), a
two-stepanti-solventcrystallizationof artemisininfromcrudefraclionsissuggested:Thefirst
stepis perfonnedby feedingacetonitrileto the diehloromethanesolutionto removethe
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Fig. 4 XRPD of theartemisinincrystalsresultedfromtheanti-solventcrystallizationsCa)
Triclinicronnfrom[9J; (b)Crystalsdriedfromethylacetatesolution;(c) Crystalsfromanti-
solventcrystallizationin acetonesolutionwithfastanti.solventfeeding;(d) Crystalsfrom
anti-solventcrystallizationin acetonitrilesolution with fast anti.solventfeeding;Ce)
Orthohombiefonnfrnm[9].
Theflltm"(,boot'mUwas,n,lv"d with"PLC.,ndtheounccn""ionofanemi,inl"was<0.2mglmi
Fig. 5 Schematicprocessflow diagramof thetwo-slepcrystallizationprocessforartemisinin
isolation.
Combinedfractions MI M2 M3 M4
Volumelm\) 460 580 200 390
Artemisinin 1.337 0.209 0.113 0.286
concentration(mg/m\)
Composition Artemisinin Artemisinin ArtemisininArtemsinin and
and impuritiesandimpurityB impurityC
A andB
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Fmctions M3 and M4 from the CC fmctionalion step were not brought 10the crystallization
slep, due to the low total amouutof artemisiuin in the solutions. The separationof artemisinin
in thesemixtures will be studied in the futurewhen more A. annua extractare fractionatedby
Cc.
NewCrystalline Solvatesof AtorvastatinCalcinm
Y ong Suk Jin, Joachim Ulrich
4 Conclusions
Thetraditionalherbalmedicinescouldserveasa sourceof inspimtionfordrugdevelopment,
and it has drawn a renewedinterestfrom the phannaceuticalindustryrecently.The
developmentof drugsfromnaturalplantsusuallyrequirestheisolationandpurificationof the
target compoundfrom a complex multi-componeutmixture. The chromatography-
crystallizationhybridsepamtionprocesssuggestedin thepresentworkmightbe oneof the
mostpromisingtechniquesforthiskindof nahtralproductseparations.
Martin-Luther-Universitat Halle-Wittenberg,Zentrum fUr lngenieurwissenschaften,
Verfahrenstechnik/TVT, D-06099 Halle (Saale), Gennany
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Atarvastalincalcium(ATC) is widelyprescribedliS'chlllesteral-laweringagentand is the
wadd's best-sellingmedicine.A large numberaf crystallillefaems IIf ATC havebeell
publishedill patents.In thiswork,twonewcrystallineslllvateswerediscavered.Commlln
oystallizalioll metlwds were used ta find theseforms fram amorphousATC. Foe




The phenomenonof polymorphism is important in the pharmaceuticalfield becausedifferent
solid forms may exhibit different physical propertiesrelatedto solubility, stability, dissolution
rate,bioavailability and so on [HaI69, Bri99]. Most pharmaceuticalproductsare used in solid
fonns, thus theinvestigationof various solid forms is crucial for the selectionof the bestform
for the intendeduse and improvement of the perfonnanee of drugs [HiI06]. In addition, the
transfonnation behavior of polymorphs and solvates in crystallization are often complicated
and difftcult to understandcompletely.Therefore, a study on this matteris significant in order
to design or control a process to getthesolid fonn with desiredproperties[Ulr05].
Atorvastatin usedas a cholesterol-lowering agentfor the treatmentofhypercholesterolemia is
a syntheticstatin,3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductaseinhibitor,
which catalyzes the rate-limiting step in cholesterol biosynthesis [Lea97]. Atorvastatin was
marketedas its calcium salt (2:1) in crystalline trihydratedesignatedforn1I (Lipitor; Warner-
Lambert, now Pfizer) [Bri97]. Lipitor becamethe world's best-selling medicine with salesof
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Fig, I Chemical structureof atorvastatincalcium (A TC).
Competitionsandchallengesbetweeninnovatorandgenericdrugmanufacturerspromptedby
thehugemarketsizehavebeenleadingto thelargenumberof patentsconcerningdifferent
crystallinefonnsas well as processesfor amorphousforms.Surprisingly,in our literature
